TLK2 and breast carcinoma: Here we discovered that TLK2 overexpression endows enhanced invasiveness of luminal breast cancers, and appears to be addictive for TLK2-amplified breast cancers so that TLK2 inhibition renders decreased cancer cell viability and increased apoptosis.